High Dose (8mg) Aflibercept for Treatment of Neovascular AMD
High Dose (8mg) Aflibercept for Treatment of Neovascular AMD
We discuss the results of a Phase II clinical trail studying the efficacy of high dose aflibercept (8mg) for treating ne... Read more
7 Jul 2022
•
9mins
New Developments in the Management of Choroidal Melanoma
New Developments in the Management of Choroidal Melanoma
We discuss new developments in the diagnosis and therapy of choroidal melanoma with Dr. Paul Finger, Clinical Professor,... Read more
30 Jun 2022
•
20mins
A Stem Cell Implant for the Treatment of Geographic Atrophy
A Stem Cell Implant for the Treatment of Geographic Atrophy
We discuss the two year results of a Phase I/II trial of a stem cell implant for the treatment of geographic atrophy wi... Read more
23 Jun 2022
•
15mins
DERBY and OAKS Results
DERBY and OAKS Results
We discuss the one year results of the DERBY and OAKs studies treating geographic atrophy with Dr. David Lally, Assista... Read more
16 Jun 2022
•
22mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Artificial Intelligence in the Management of Macular Degeneration
Artificial Intelligence in the Management of Macular Degeneration
We discuss the use of deep learning techniques in the detection and management of macular degeneration with Dr. Pearse K... Read more
9 Jun 2022
•
18mins
An Oral Agent for the Treatment of Diabetic Retinopathy
An Oral Agent for the Treatment of Diabetic Retinopathy
In our latest update, We discuss the use of APX3330 a novel oral agent for the treatment of diabetic retinopathy with Dr... Read more
2 Jun 2022
•
9mins
Home OCT Monitoring of Neovascular AMD Treatment
Home OCT Monitoring of Neovascular AMD Treatment
We discuss the use of a home based OCT system with artificial intelligence to monitor the treatment of neovascular AMD w... Read more
26 May 2022
•
15mins
Faricimab in Diabetic Macular Edema: 2 Year Results of the RHINE and YOSEMITE studies
Faricimab in Diabetic Macular Edema: 2 Year Results of the RHINE and YOSEMITE studies
We discuss the two year results of the first bispecific agent for the treatment of diabetic macular edema with Dr. John ... Read more
19 May 2022
•
15mins
The Kingfisher Trial of Brolucizumab for DME
The Kingfisher Trial of Brolucizumab for DME
We discuss the results of the Kingfisher trail, a study employing broluizumab q4 weeks for the treatment of diabetic mac... Read more
12 May 2022
•
10mins
Subretinal Fluid in Neovascular AMD: Friend or Foe?
Subretinal Fluid in Neovascular AMD: Friend or Foe?
We examine the role of sub retinal fluid in the treatment of neovascular AMD with Dr. David Sarraf, Professor of Ophthal... Read more
5 May 2022
•
10mins
